Autophagy activation in granulosa cells as a mechanism of astaxanthin action: evidence from a pilot randomised trial in PMOS-associated infertility.

Hum Fertil (Camb)Sep 10, 2026 (epub)
Clinical ResearchObstetrics & Gynecology

Arezoo Maleki-Hajiagha, Ashraf Aleyasin, Fardin Amidi

✦ AI-curated · Sources linked

In 30 seconds

This pilot randomized trial investigated the effects of astaxanthin (AST) on autophagy in granulosa cells among 50 women with PMOS-related infertility. AST supplementation significantly increased total oocyte yield and mature oocyte yield compared to placebo. The study highlights AST's potential role in enhancing oocyte competence and embryo quality through autophagy modulation.

Key findings

  • AST increased autophagy-related gene 7 (ATG7) expression and enhanced autophagy flux.
  • Total oocyte yield and mature oocyte yield were significantly higher with AST after adjustment.
  • The top-ranking embryo rate was significantly higher in the AST group after adjustment.

Why it matters

Understanding the role of autophagy in ovarian function could inform treatment strategies for women with PMOS-related infertility. Enhancing oocyte quality and quantity may improve reproductive outcomes in this population.

Source

Published in Hum Fertil (Camb). This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Obstetrics & Gynecology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.